Raab & Moskowitz Asset Management’s Core Laboratories CLB Stock Holding History

Raab & Moskowitz Asset Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,910	Closed	-$71K	–	200
2019 Q4	$71K	Buy	+1,910	New	+$85.8K	0.03%	217
2018 Q4	–	Sell	-1,910	Closed	-$221K	–	216
2018 Q3	$221K	Hold	1,910	–	–	0.09%	158
2018 Q2	$241K	Hold	1,910	–	–	0.12%	142
2018 Q1	$206K	Buy	+1,910	New	+$211K	0.1%	154

Other funds holding CLB

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Raab & Moskowitz Asset Management's CLB Position: Q1 2020 in Review

Raab & Moskowitz Asset Management sold out of Core Laboratories (CLB) in Q1 2020, closing a stake of 1,910 shares — an estimated $71K sold.

Raab & Moskowitz Asset Management first reported a position in CLB in Q1 2018 and held it in 4 quarters. The position peaked at $241K in Q2 2018. 207 funds tracked by Wall St. Rank hold CLB as of Q1 2020.

Raab & Moskowitz Asset Management reported no remaining Core Laboratories position as of Q1 2020 after selling out during the quarter.
Raab & Moskowitz Asset Management sold 1,910 Core Laboratories shares in Q1 2020, an estimated $71K.
Raab & Moskowitz Asset Management first reported a position in Core Laboratories in Q1 2018 and held it in 4 quarters.
Raab & Moskowitz Asset Management's Core Laboratories position peaked at $241K in Q2 2018.
207 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2020.

Based on Raab & Moskowitz Asset Management's 13F filing for Q1 2020, filed 14 May 2020.